SCHEMBL6206669

SCHEMBL6206669

CC(C)(C)OC(=O)NCCC[C@H](O)c1nc2ncccc2o1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.43
GAA P10253 1/20 0.43
KMT2A Q03164 1/20 0.43
SHMT2 P34897 1/20 0.43
KDM4E B2RXH2 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 1/20 0.41
STK17B O94768 1/20 0.41
STK17A Q9UEE5 1/20 0.41
CYP3A4 P08684 1/20 0.41
FAAH O00519 9/20 0.40
DAGLA Q9Y4D2 5/20 0.39
CYP1A1 P04798 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2B6 P20813 1/20 0.39
CYP2C19 P33261 1/20 0.39
CYP3A43 Q9HB55 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5489553 1.00 MEN1 (0.43) MEN1GAAKMT2ASHMT2KDM4E
SCHEMBL6206334 0.84 MEN1 (0.46) MEN1GAAKMT2AMAPTSTK17B
SCHEMBL3620326 0.79 NPC1 (0.40) SHMT2MAPTFAAHDAGLA
SCHEMBL7723226 0.78 MAPT (0.38) MEN1KMT2AMAPTCYP3A4FAAH
SCHEMBL5947648 0.78 NPC1 (0.41) MEN1GAAKMT2ASHMT2KDM4E
SCHEMBL5947645 0.78 NPC1 (0.41) MEN1GAAKMT2ASHMT2KDM4E
SCHEMBL3627060 0.77 FAAH (0.40) SHMT2MAPTFAAHDAGLA
SCHEMBL3622704 0.77 FAAH (0.40) SHMT2MAPTFAAHDAGLA
SCHEMBL13504879 0.77 FAAH (0.40) SHMT2MAPTFAAHDAGLA
SCHEMBL3622701 0.77 FAAH (0.40) SHMT2MAPTFAAHDAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515726-A1 MORPHOLINE AND TETRAHYDROPYRAN DERIVATIVES AND THEIR USE AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2005-03-23 EP disclosed
WO-2004002491-A1 MORPHOLINE AND TETRAHYDROPYRAN DRIVATIVES AND THEIR USE AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2004-01-08 WO disclosed